Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check22 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.4%
- Check37 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the old revision tag was removed and the Back to Top element was removed.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as new information regarding drug safety and counterfeit drugs. The revision number has also been updated to v3.0.0.SummaryDifference6%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.